| Literature DB >> 32493177 |
Seyed Arad Senaobar Tahaei1, Zoltan Mencser1, Zita Reisz1, Pal Barzo1.
Abstract
Septic cerebral emboli can be a challenging diagnosis to give, especially if atypical bacterial infections are the cause of it. Correct diagnosis of this condition can change the management route of the patient and result in a nonsurgical treatment. To our best knowledge, this is the first case of septic cerebral embolus caused by Corynebacterium mucifaciens reported. In this study, a 65-year-old diabetic patient who have developed ketoacidosis and went into coma was investigated for a case of septic cerebral embolization. The patient developed a sudden right-sided hemiparesis, and the radiological findings showed a tumor-like lesion on the left hemisphere at the level of the internal capsule. At first glance, presence of a metastatic tumor could not be excluded; therefore, further laboratory tests and examinations were done to rule out metastatic lesions. The blood culture of the patient revealed a case of bacteremia caused by Corynebacterium mucifaciens and then a septic cerebral embolus was suspected, but due to the rarity of this pathogen causing such complications as well as the similarity of the lesion to a metastatic brain tumor, a biopsy was performed and the histopathological findings confirmed the diagnosis of a septic cerebral embolus. Corynebacterium mucifaciens should be considered a human pathogen in immunocompromised patients and it can cause cerebral septic embolization. Metastatic brain tumors and tuberculomas should be excluded; if the uncertainty of a metastatic tumor remains, biopsy can be performed and histological findings can amplify the diagnosis of septic cerebral embolus.Entities:
Keywords: Corynebacterium mucifaciens; diabetic patient; immunosuppressed patient; metastatic-like lesion; septic cerebral embolism; tumor-like lesion
Mesh:
Year: 2020 PMID: 32493177 PMCID: PMC7273552 DOI: 10.1177/2324709620930930
Source DB: PubMed Journal: J Investig Med High Impact Case Rep ISSN: 2324-7096
Figure 1.The contrast-enhanced computed tomography scans showing a cystic-like lesion at the level of the internal capsule on the left side.
Figure 2.The coronal view on the T1WI shows a peripheral hyperintense rim with hypointense signals within the lesion.
Figure 3.The post-Gd, T2 FLAIR and DWI sequences of the lesion, showing peripheral rim enhancement with surrounding white matter edema.
The Antibiotic Susceptibility Spectrum of Corynebacterium mucifaciens, Cultured Out From the Blood Samples.
| Penicillin | Resistant |
| Ciprofloxacin | Resistant |
| Vancomycin | Susceptible |
| Clindamycin | Susceptible |
| Gentamicin | Susceptible |
| Rifampicin | Susceptible |
| Moxifloxacin | Susceptible |
| Tetracyclin | Susceptible |
Figure 4.The microscopic findings and features of the biopsied tissue, showing confluent central necrosis containing necrotic debris and neutrophils as well as poor demarcation from the adjacent brain parenchyma.
Figure 5.The control postoperative magnetic resonance imaging scans after 3 months show a significant regression of the lesion.
Figure 6.The contrast-enhanced magnetic resonance imaging scans after 1 year show a complete regression of the lesion on the left side. Some artifacts of the biopsy can be seen in the surroundings of the surgical site.